Stock Movers

Oracle faces delays on its OpenAI data centers, pushing completion to 2028, raising concerns among investors. Meanwhile, Broadcom's stock takes a hit as its $73 billion AI backlog fails to meet expectations, despite claiming it's a minimum figure. In a contrasting move, Lululemon's shares surge 14% following the news of its CEO stepping down, hinting at a strategic shift after a significant decline in sales. Tune in for insights into these market shifts and more!

Denitza Sokova, a Bloomberg reporter specializing in market-moving news, shares insights on various stocks. She reveals Broadcom's $73 billion AI backlog, which disappointed investors despite being termed a 'minimum' number. Lululemon sees a surge in shares after raising its outlook and announcing CEO Calvin McDonald's upcoming departure. Meanwhile, Citigroup's shares rise, backed by bullish comments on Boeing's management changes. Denitza's analysis provides a fascinating glimpse into the shifting dynamics of these major companies.

Lululemon is on the rise, boosting its outlook and preparing for a CEO transition, which analysts see as overdue. Meanwhile, Broadcom struggles with disappointing AI revenue projections, leaving investors feeling uneasy. On a lighter note, Tilray Brands and other cannabis stocks are soaring as President Trump hints at reclassifying marijuana, though there's uncertainty about whether this policy will hold. The podcast dives deep into the dynamics shaping these companies and their industries.

Broadcom's sales outlook has investors skittish after disappointing news about its massive $73 billion AI backlog. Lululemon, on the other hand, is riding high with increased earnings guidance and a major stock buyback, despite facing leadership changes. Meanwhile, cannabis stocks are soaring on the heels of potential rescheduling discussions, which could ease federal restrictions. The hosts dive into the implications of these developments for the market.

Broadcom's shares dipped as its sales outlook disappointed investors, despite a massive $73 billion AI backlog. Lululemon saw a surge in stock price after boosting its earnings guidance and showing strong international growth, while also announcing a CEO departure. Meanwhile, UBS's shares climbed to a 17-year high following a proposal for capital relief from Swiss lawmakers. In an unexpected twist, reports of President Trump possibly reclassifying cannabis sparked a rally in cannabis stocks!

Louise Moon, Breaking News Editor at Bloomberg, shares her insights on market movements. She highlights UBS's impressive surge, driven by potential changes to capital demands. Lufthansa also shines, with an upgrade from Kepler Cheuvreux thanks to strong travel trends. Meanwhile, Card Factory faces turmoil as their profit warning leads to a dramatic share drop. Moon's analysis sheds light on these significant market shifts, making for an engaging discussion!

Louise Moon, a Bloomberg reporter with expertise in European markets and banking, dives into the latest trends impacting UBS, Standard Chartered, and Adidas. She highlights UBS's shares skyrocketing after lawmakers proposed easing capital demands, creating excitement in the market. Standard Chartered gains traction following a buy upgrade from Goldman Sachs, thanks to improving profitability. Lastly, she connects Lululemon's strong outlook to a bullish sentiment for Adidas, suggesting continued sales strength ahead.

Jordan Fitzgerald, an equities reporter for Bloomberg News, dives into the latest market movers. He highlights Broadcom's impressive forecast, expecting AI semiconductor revenue to double, signaling robust demand. Lululemon's shares soar after announcing a leadership shake-up and an optimistic outlook, while Oracle faces a steep decline due to disappointing cloud sales growth projections. The discussion sheds light on the reaction of analysts and investors to these transformative shifts in major companies.

Fertilizer stocks saw a significant surge after drone strikes on Russian plants raised supply chain concerns. Eli Lilly's promising obesity drug results are set to shake up the weight-loss market, with shares climbing. Lululemon's after-hours jump followed strong earnings and an unexpected CEO departure, leaving investors curious about succession plans. The podcast also touches upon Disney's hefty investment in OpenAI and Oracle's alarming stock drop amid rising tech costs. It's a whirlwind of market insights and surprising shifts!

Eli Lilly's latest obesity drug shows remarkable potential, helping patients shed nearly 25% of their weight, along with other health benefits. Meanwhile, Gemini Space Station celebrates a 20% stock surge after gaining CFTC approval for a derivatives exchange, opening doors to prediction markets. On the downside, Oracle faces a hefty 13% drop as its cloud sales forecast disappoints, raising concerns about its revenue conversion amidst supply challenges.